Surgery vs surgery and chemotherapy for colorectal liver metastases

The Lancet

Volumn 372, Issue 9634, 2008, Pages 202-203

  Snoeren, N ^a   Voest, E ^a   van Hillegersberg, R ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CANCER; HUMAN; INTERMETHOD COMPARISON; LETTER; LIVER METASTASIS; POSTOPERATIVE CARE; PREOPERATIVE CARE; PRIORITY JOURNAL; TREATMENT RESPONSE;

EID: 47149103525     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(08)61063-6     Document Type: Letter

References (3)

1. Nordlinger B., Sorbye H., Glimelius B., et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40 983): a randomised controlled trial. Lancet 371 (2008) 1007-1016
2. Adam R., Wicherts D., de Haas R., et al. Complete pathologic response after preoperative chemotherapy for colorectal liver metastases: myth or reality?. J Clin Oncol 26 (2008) 1635-1641
3. Portier G., Elias D., Bouche O., et al. Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial. J Clin Oncol 24 (2006) 4976-4982